We provide continuous financial coverage including stock performance, earnings expectations, and broader economic indicators.
As of April 6, 2026, Pliant Therapeutics Inc. (PLRX) trades at $1.36, posting a mild 0.74% gain on the session. This analysis focuses on key technical levels and market dynamics shaping the biotech stock’s near-term trading activity, as no recent earnings data is available for the company at this time. PLRX, which focuses on developing novel therapies for fibrotic diseases, has traded in a tight range in recent weeks, with price action largely driven by broader sector sentiment and technical tra
Is Pliant Therapeutics (PLRX) Stock Lagging the Market | Price at $1.36, Up 0.74% - Wave Extension
PLRX - Stock Analysis
3308 Comments
1470 Likes
1
Soyla
Returning User
2 hours ago
{协议答案}
👍 198
Reply
2
Lynnanne
Returning User
5 hours ago
{协议答案}
👍 57
Reply
3
Shelbert
Expert Member
1 day ago
{协议答案}
👍 287
Reply
4
Kinjal
Senior Contributor
1 day ago
{协议答案}
👍 210
Reply
5
Januelle
Returning User
2 days ago
{协议答案}
👍 136
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.